How is asymptomatic antithrombin III (ATIII) deficiency treated?

Updated: Mar 04, 2020
  • Author: James L Harper, MD; Chief Editor: Hassan M Yaish, MD  more...
  • Print
Answer

Asymptomatic carriers should not receive anticoagulation therapy, because the risk of thrombosis does not exceed the bleeding risk associated with anticoagulation therapy. [18, 19]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!